Olin Guides for Sharp Q2 Improvement, But Execution Risks Remain

What happened

Olin management used the Q1 earnings call to forecast a sharp sequential improvement in Q2 earnings, citing higher pricing, seasonal demand, and cost reductions from the Beyond250 program. While this optimistic outlook suggests near-term momentum, the company still faces substantial headwinds including a $185 million cash payment to Shintech in 1H26 and net debt/EBITDA of 5.17x. The Master Report's base case values Olin at $26, implying limited upside from the current $24.34 price, and a 'WAIT' rating reflects the need for proof of execution. Investors should be wary of management's track record of guidance cuts and the persistent risk that chlorine demand fails to stabilize, prolonging the trough. The Q2 guidance is a positive data point, but the thesis remains execution-dependent, with key checkpoints in the coming months.

Implication

The Q2 guidance aligns with the Master Report's base case trajectory, but we need to see if Beyond250 savings and epoxy profitability actually deliver. The stock's attractive entry remains around $20, and any Q2 beat could be a selling opportunity if it fails to address underlying leverage and cash flow concerns. The thesis hinges on observable 1H26 execution, not on forward guidance.

Thesis delta

The Q1 call adds a positive near-term catalyst, shifting sentiment from purely trough-watching to expecting a sequential recovery. However, this does not change the fundamental assessment: Olin still needs to prove that self-help can offset weak ECU economics. The 'WAIT' rating stands because the valuation already prices in a recovery, and risk of disappointment remains high given the Shintech payment and potential for maintenance capex creep.